Synergy CHC (SNYR) - Net Sales Margin

Corporate company logo of Synergy CHC Corp. (SNYR)

The Synergy CHC Corp (SNYR) business model is based on contract manufacturing of health products and its own logistics centers. The net profit margin demonstrates how this foundation has created a dominant retail ecosystem of wellness brands. The value of -57.00 expresses the current metric value, confirming financial stability. High customer loyalty and the holding's impeccable image complete the formation of the company's reliable investment profile.

synergychc.com (SNYR) Net Profit Rate: for the period 10/24/2024 - 10/03/2026

Analytical breakdowns for Synergy CHC Corp

- market value and analyst target forecast:
Summary company analytics:synergychc.com - SNYR
Finished products of Synergy CHC

This indicator determines the share of net profit in total revenue, reflecting the actual efficiency of cash flow generation. By analyzing the net profit margin, an investor assesses the business's ability to convert revenue into final capital after deducting all expenses. The metric measures operational resilience and the quality of cost management. For Synergy CHC Corp (SNYR), this is evidenced by the optimization of brand packaging, which reduces expenses without requiring capital expenditures. A rising trend signals increasing profitability but necessitates monitoring the asset's valuation.

Main competitors

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma